Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for hospitalized patients with COVID-19 and respiratory failure
2020-001473-79Phase 3Unknown
- Sponsor
- Saint Luke's Hospital of Kansas City
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Dapagliflozin with Placebo (2 arms). Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001473-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001473-79.